The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626001231336
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
16/09/2026
Date registered
Help: Date registered
8/10/2026
Date last updated
Help: Date last updated
8/10/2026
Date data sharing statement initially provided
Help: Data sharing statement date
8/10/2026
Type of registration
Help: Type of registration
Retrospectively registered

Titles & IDs
Public title
Effectiveness, feasibility, and acceptability of a new intervention targeting body image and wellbeing for people with inflammatory bowel disease
Scientific title
Effectiveness, feasibility, and acceptability of an online intervention targeting body image and psychological wellbeing in adults with inflammatory bowel disease: a pilot randomised controlled trial
Additional trial identifiers [1] 318394 0
Nil known
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
inflammatory bowel disease 343537 0
Condition category
Condition code
Oral and Gastrointestinal 339645 339645 0 0
Inflammatory bowel disease

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Arm 1 – Intervention: Participants received a digital, self-paced psychological intervention designed to improve body image and wellbeing in adults with inflammatory bowel disease (IBD). The intervention comprised 10 online modules (“chapters”) delivered via Qualtrics over approximately three weeks, with chapters sent every few days. Each chapter took approximately 5–20 minutes to complete. Module content was primarily text-based and included brief psychoeducation, participant prompts and guided reflections, and interactive skills-based activities and exercises. Activities included strategies such as goal setting, writing tasks, identifying and challenging unhelpful thoughts, body functionality exercises, mindfulness, self-compassion, and reflection activities.

The intervention was co-designed with 10 people with IBD and body image dissatisfaction (8 women and 2 men; mean age approximately 35 years). Participants took part in three co-design workshops, each lasting approximately three hours, conducted during May and June 2023. Participants could attend either in person or online via Microsoft Teams, with five participants attending in each format.

The co-design process combined existing evidence-based knowledge and strategies from body image, disordered eating, and broader mental health interventions with the lived experience and perspectives of people with IBD. Prior to the first workshop, participants reviewed lay-language information about body image and existing positive body image interventions. During Workshop 1, participants discussed how IBD affected their body image and wellbeing and provided preliminary feedback regarding potentially appropriate intervention approaches, delivery format, and duration. During Workshop 2, participants reviewed and discussed proposed intervention components and examples of strategies, including mindfulness, cognitive behavioural approaches, body functionality, goal setting, self-compassion, and gratitude, and provided feedback on their relevance and how they should be adapted for people with IBD. Prior to Workshop 3, a prototype of the intervention was developed in Qualtrics. Participants then reviewed each proposed chapter, including the psychoeducation, prompts, activities, wording, and presentation, and provided feedback regarding usefulness, engagement, and suitability. Participant feedback from the workshops was incorporated into the final intervention.

Participants completed outcome assessments at baseline, post-intervention, and one-month follow-up.
Intervention code [1] 335290 0
Behaviour
Description of the comparator or control
Participants allocated to the waitlist control condition did not receive the intervention during the initial study period. They completed the same outcome assessments as the intervention group at baseline, after approximately three weeks, and at one-month follow-up. After completing their final questionnaire, participants in the waitlist control group were offered access to the intervention.
Control group
Active

Outcomes
Primary outcome [1] 346819 0
Body dissatisfaction
Timepoint [1] 346819 0
Baseline, immediately following completion of the 3-week intervention (post-intervention; primary timepoint), and 1-month follow-up.
Secondary outcome [1] 467678 0
Body appreciation
Timepoint [1] 467678 0
Baseline, immediately following completion of the 3-week intervention (post-intervention), and 1-month follow-up.
Secondary outcome [2] 467679 0
Eating disorder psychopathology
Timepoint [2] 467679 0
Baseline, immediately following completion of the 3-week intervention (post-intervention), and 1-month follow-up.
Secondary outcome [3] 467680 0
Depressive symptoms
Timepoint [3] 467680 0
Baseline, immediately following completion of the 3-week intervention (post-intervention), and 1-month follow-up.
Secondary outcome [4] 467681 0
Anxiety symptoms
Timepoint [4] 467681 0
Baseline, immediately following completion of the 3-week intervention (post-intervention), and 1-month follow-up.
Secondary outcome [5] 467684 0
Health-related quality of life / health status
Timepoint [5] 467684 0
Baseline, immediately following completion of the 3-week intervention (post-intervention), and 1-month follow-up.

Eligibility
Key inclusion criteria
Diagnosis of inflammatory bowel disease (IBD), including Crohn’s disease or ulcerative colitis.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Participants were excluded if they were under 18 years of age or did not have a diagnosis of inflammatory bowel disease. No other specific exclusion criteria were applied.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation was concealed through automated randomisation within Qualtrics. Group assignment was generated only after enrolment, and the allocation could not be predicted in advance.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Computer-generated random allocation using the Qualtrics randomiser, with participants randomly assigned to either the intervention or waitlist control group.
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
ACT,NSW,NT,QLD,SA,WA,VIC
Recruitment hospital [1] 30210 0
Flinders Medical Centre - Bedford Park
Recruitment postcode(s) [1] 46604 0
5042 - Bedford Park

Funding & Sponsors
Funding source category [1] 322970 0
Government body
Name [1] 322970 0
Southern Adelaide Local Health Network (SALHN)
Country [1] 322970 0
Australia
Primary sponsor type
University
Name
Flinders University
Address
Country
Australia
Secondary sponsor category [1] 325895 0
Hospital
Name [1] 325895 0
Flinders Medical Centre
Address [1] 325895 0
Country [1] 325895 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 321381 0
Southern Cross University Human Research Ethics Committee
Ethics committee address [1] 321381 0
Ethics committee country [1] 321381 0
Australia
Date submitted for ethics approval [1] 321381 0
27/01/2023
Approval date [1] 321381 0
28/02/2023
Ethics approval number [1] 321381 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 153554 0
Dr Mia Pellizzer
Address 153554 0
Flinders University, Sturt Road Bedford Park 5043 SA
Country 153554 0
Australia
Phone 153554 0
+61 0882013664
Fax 153554 0
Email 153554 0
Contact person for public queries
Name 153555 0
Mia Pellizzer
Address 153555 0
Flinders University, Sturt Road Bedford Park 5043 SA
Country 153555 0
Australia
Phone 153555 0
+61 0882013664
Fax 153555 0
Email 153555 0
Contact person for scientific queries
Name 153556 0
Mia Pellizzer
Address 153556 0
Flinders University, Sturt Road Bedford Park 5043 SA
Country 153556 0
Australia
Phone 153556 0
+61 0882013664
Fax 153556 0
Email 153556 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.